We are live on ! Find out more
IKT icon

Inhibikase Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
SCV
1
Sands Capital Ventures
Virginia
$17.7M
SCM
2
Soleus Capital Management
Connecticut
$10.2M
FFM
3
Fairmount Funds Management
Pennsylvania
$9.92M
PA
4
Perceptive Advisors
New York
$8.78M -$18.6K -10,725 -0.2%
CC
5
Commodore Capital
New York
$8.74M
ACM
6
ADAR1 Capital Management
Texas
$8.5M +$217K +125,498 +2%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.3M +$84.8K +48,969 +2%
BlackRock
8
BlackRock
New York
$4.98M +$601K +347,018 +13%
Blackstone Inc
9
Blackstone Inc
New York
$4.27M
NCM
10
Nantahala Capital Management
Connecticut
$3.55M
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.8M +$79.5K +45,874 +4%
SCM
12
Stonepine Capital Management
Oregon
$1.19M +$2.12K +1,226 +0.2%
State Street
13
State Street
Massachusetts
$823K +$190K +109,937 +28%
Northern Trust
14
Northern Trust
Illinois
$606K -$31.8K -18,380 -5%
William Blair & Company
15
William Blair & Company
Illinois
$248K -$6.93K -4,000 -3%
Charles Schwab
16
Charles Schwab
California
$247K
Bank of New York Mellon
17
Bank of New York Mellon
New York
$225K +$10.7K +6,194 +5%
UBS Group
18
UBS Group
Switzerland
$221K +$169K +97,606 +252%
Fidelity Investments
19
Fidelity Investments
Massachusetts
$171K -$66.6K -38,469 -27%
Barclays
20
Barclays
United Kingdom
$139K -$42.7K -24,674 -22%
Deutsche Bank
21
Deutsche Bank
Germany
$130K +$139K +80,496 New
Nuveen
22
Nuveen
North Carolina
$127K
Citadel Advisors
23
Citadel Advisors
Florida
$116K +$124K +71,670 New
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$93.2K -$1.69K -973 -2%
Morgan Stanley
25
Morgan Stanley
New York
$90.8K -$75.6K -43,659 -44%